PlexusDx exclusively partners with 503A compounding pharmacies to ensure direct patient accountability and adherence to traditional pharmacy standards
In laboratory research, administering 5-Amino-1MQ competitively inhibits NNMT activity, halting the clearance of nicotinamide
This effect was confirmed in mice, where significantly lower citrulline values were observed in plasma, skeletal muscle, and adipose tissue of metformin-treated animals (Adam et al., 2016)
PlexusDx takes a precision-wellness approach: evaluating not just surgical history, but current thyroid function, metabolic biomarkers, and individual peptide-pathway predispositions to inform safer, more personalized treatment planning
A.DoverspikeA.HentoszT.ZoureliasL.ShenY
A.-T., Frohlich, B., Mininberg, D